Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 83-89, March 2009

Liposomes targeted by fusion phage proteins

  • Prashanth K. Jayanna, DVM

      Affiliations

    • Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA
  • ,
  • Vladimir P. Torchilin, PhD, DSc

      Affiliations

    • Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts
  • ,
  • Valery A. Petrenko, PhD, DSc

      Affiliations

    • Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA
    • Corresponding Author InformationCorresponding author. Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama 36849, USA.

Received 7 February 2008; accepted 21 July 2008. published online 02 October 2008.

Abstract 

Targeting of nanocarriers has long been sought after to improve the therapeutic indices of anticancer drugs. Here we provide the proof of principle for a novel approach of nanocarrier targeting through their fusion with target-specific phage coat proteins. The source of the targeted phage coat proteins are landscape phage libraries—collections of recombinant filamentous phages with foreign random peptides fused to all 4000 copies of the major coat protein. We exploit in our approach the intrinsic physicochemical properties of the phage major coat protein as a typical membrane protein. Landscape phage peptides specific for specific tumors can be obtained by affinity selection, and purified fusion coat proteins can be assimilated into liposomes to obtain specific drug-loaded nanocarriers. As a paradigm for inceptive experiments, a streptavidin-specific phage peptide selected from a landscape phage library was incorporated into ∼100-nm liposomes. Targeting of liposomes was proved by their specific binding to streptavidin-coated beads.

Key words: Fusion phage, Tumor targeting, Streptavidin, Liposomes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by National Institutes of Health grant NIH-1 R21 AI055645 (to V.A.P.) and Animal Health and Disease Research grant 2006-9 (College of Veterinary Medicine, Auburn University) to V.A.P.

PII: S1549-9634(08)00121-4

doi:10.1016/j.nano.2008.07.006

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 83-89, March 2009